Word

JOURNESS

Status

Pending

Status Code

688

Status Date

Tuesday, January 30, 2024

Serial Number

97794287

Mark Type

4000

Filing Date

Tuesday, February 14, 2023

Published for Opposition

Tuesday, December 5, 2023

Trademark Owner History

TEVA PHARMACEUTICALS USA, Inc. - Owner At Publication

Classifications

5 Pharmaceutical preparations for the prevention and treatment of autoimmune diseases and disorders, blood and circulatory diseases and disorders, cardiovascular diseases and disorders, digestive diseases and disorders, endocrine diseases and disorders, immunological diseases and disorders, dermatological diseases and disorders, musculoskeletal diseases and disorders, central and peripheral nervous system diseases and disorders, metabolic diseases and disorders, renal diseases and disorders, respiratory diseases and disorders, urogenital diseases and disorders, and urinary diseases and disorders; pharmaceutical preparations for use in the treatment of cancer, drug dependence, fertility disorders, hormone replacement, infectious diseases, inflammatory conditions, menopause, ophthalmic disorders and diseases, pain, and psychological disorders; pharmaceutical preparations for use in smoking cessation; contraceptive preparations

Trademark Events

Jan 30, 2024

Noa E-Mailed - Sou Required From Applicant

Dec 5, 2023

Official Gazette Publication Confirmation E-Mailed

Dec 5, 2023

Published For Opposition

Nov 15, 2023

Notification Of Notice Of Publication E-Mailed

Nov 1, 2023

Approved For Pub - Principal Register

Nov 1, 2023

Examiner's Amendment Entered

Nov 1, 2023

Notification Of Examiners Amendment E-Mailed

Nov 1, 2023

Examiners Amendment E-Mailed

Nov 1, 2023

Examiners Amendment -Written

Oct 30, 2023

Assigned To Examiner

Mar 4, 2023

New Application Office Supplied Data Entered

Feb 17, 2023

New Application Entered